
Tesla, Inc.
- What it sells
- Automotive Revenues is 73% of revenue (fiscal year to Dec 2025), down from 85% two years earlier.
- Growing?
- Flat: revenue about the same as a year earlier (quarter ended Sep 2026); earnings per share down 37% over the last four quarters.
- Expensive?
- Pricier than usual: 437× trailing earnings; its five-year median is 107×.
- Analysts?
- 48% of 44 say buy; average 12-month target $412, 4% above today's price.
- Risky?
- Swingier than most large companies: its price swung 46% over the past year (the S&P 500's 14%), and it fell as much as 73% since Nov 2021.
Tesla, Inc. designs, manufactures, and sells battery-electric vehicles (notably Model 3, Model Y, Model S, Model X, and Cybertruck) and provides energy generation and storage products such as Powerwall, Megapack, and Solar Roof.
More about Tesla
Revenue is primarily from automotive sales and automotive leasing, with additional revenue from energy generation and storage and services and other (e.g., Supercharging, service, and other after-sales offerings).
Market Position
Tesla is a leading U.S.-listed EV manufacturer differentiated by a large installed vehicle fleet, over-the-air software capabilities, an integrated Supercharger fast-charging network, and vertically integrated manufacturing of key EV systems. Competitive pressure is driven by incumbent automakers’ EV lineups and other EV-focused OEMs, with pricing and product cadence influencing demand.
Key Segments
Tesla reports results across Automotive and Energy Generation and Storage, with Services and Other as an additional revenue category that includes items such as paid Supercharging and service-related revenue.
How has the stock done?
Over the past month TSLA rose 5.1%; the consumer discretionary ETF (XLY) rose 7.3% and the S&P 500 fell 2.7%.
Over the past six months TSLA fell 8.3%; the consumer discretionary ETF (XLY) rose 1.8% and the S&P 500 rose 2.6%.
Over the past year TSLA fell 7.7%; the consumer discretionary ETF (XLY) rose 1.3% and the S&P 500 rose 10.8%.
Over five years TSLA rose 15.4%; the consumer discretionary ETF (XLY) rose 18.2% and the S&P 500 rose 62.0%.
From Jan 3, 2022 to Jan 3, 2023, the deepest drop from a high since Nov 2021
How much the price swings in a year; the S&P 500's was 14%
When the S&P 500 moves 1%, the stock has moved about 2.1% the same way
Show the earnings releases
| Released | Quarter | Revenue | EPS vs estimate | Stock, day after | 5 days after |
|---|---|---|---|---|---|
| Oct 21, 2026 | ended Sep 2026 | $28.0B (0% vs a year earlier) | $0.48 vs $0.45 (beat) | +0.2% | +8.2% |
| Jul 22, 2026 | ended Jun 2026 | $28.2B (+26% vs a year earlier) | $0.33 vs $0.54 (missed) | −15.6% | −21.3% |
| Apr 22, 2026 | ended Mar 2026 | $22.4B (+16% vs a year earlier) | $0.41 vs $0.35 (beat) | −3.3% | −3.5% |
| Jan 28, 2026 | ended Dec 2025 | $24.9B (−3% vs a year earlier) | $0.50 vs $0.45 (beat) | −3.3% | −5.8% |
| Oct 22, 2025 | ended Sep 2025 | $28.1B (+12% vs a year earlier) | — | +1.4% | +4.3% |
| Jul 23, 2025 | ended Jun 2025 | $22.5B (−12% vs a year earlier) | — | −8.1% | −3.9% |
| Apr 22, 2025 | ended Mar 2025 | $19.3B (−9% vs a year earlier) | — | +10.2% | +28.4% |
| Jan 29, 2025 | ended Dec 2024 | $25.7B (+2% vs a year earlier) | — | +0.6% | −5.0% |
| Oct 23, 2024 | ended Sep 2024 | $25.2B (+8% vs a year earlier) | — | +19.5% | +18.2% |
| Jul 23, 2024 | ended Jun 2024 | $25.5B (+2% vs a year earlier) | — | −14.1% | −11.5% |
| Apr 23, 2024 | ended Mar 2024 | $21.3B (−9% vs a year earlier) | — | +14.1% | +29.0% |
| Jan 24, 2024 | ended Dec 2023 | $25.2B (+3% vs a year earlier) | — | −12.7% | −10.4% |
| Oct 18, 2023 | ended Sep 2023 | $23.4B (+9% vs a year earlier) | — | −13.6% | −16.6% |
| Jul 19, 2023 | ended Jun 2023 | $24.9B (+47% vs a year earlier) | — | −10.4% | −9.9% |
| Apr 19, 2023 | ended Mar 2023 | $23.3B (+24% vs a year earlier) | — | −11.6% | −16.6% |
| Jan 25, 2023 | ended Dec 2022 | $24.3B (+37% vs a year earlier) | — | +11.4% | +26.1% |
| Oct 19, 2022 | ended Sep 2022 | $21.5B (+56% vs a year earlier) | — | −5.9% | +2.0% |
| Jul 20, 2022 | ended Jun 2022 | $16.9B (+42% vs a year earlier) | — | +10.7% | +11.9% |
| Apr 20, 2022 | ended Mar 2022 | $18.8B (+81% vs a year earlier) | — | −1.9% | −14.3% |
| Jan 26, 2022 | ended Dec 2021 | $17.7B (+65% vs a year earlier) | — | −9.7% | −1.4% |
Change in closing price from the first day shown, or with Price the closing price itself. Prices: Yahoo Finance, to Nov 12, 2026. Dashed lines: the days the company released earnings (its SEC 8-K filings); EPS estimates: Yahoo Finance. The stock's move after a release runs from the last close before its day to the close the day after (or five days after), so a release before the open counts like one after the close.
Is the business growing?
Revenue was $28.0B in the quarter ended Sep 2026, about the same as a year earlier.
Show the data
| Quarter ended | Revenue | vs a year earlier |
|---|---|---|
| Dec 2022 | $24.3B | +37% |
| Mar 2023 | $23.3B | +24% |
| Jun 2023 | $24.9B | +47% |
| Sep 2023 | $23.4B | +9% |
| Dec 2023 | $25.2B | +3% |
| Mar 2024 | $21.3B | −9% |
| Jun 2024 | $25.5B | +2% |
| Sep 2024 | $25.2B | +8% |
| Dec 2024 | $25.7B | +2% |
| Mar 2025 | $19.3B | −9% |
| Jun 2025 | $22.5B | −12% |
| Sep 2025 | $28.1B | +12% |
| Dec 2025 | $24.9B | −3% |
| Mar 2026 | $22.4B | +16% |
| Jun 2026 | $28.2B | +26% |
| Sep 2026 | $28.0B | 0% |
Revenue went from $81.5B in FY22 to $94.8B in FY25; net income from $12.6B to $3.8B.
Show the data
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY22 | $81.5B | $12.6B |
| FY23 | $96.8B | $15.0B |
| FY24 | $97.7B | $7.1B |
| FY25 | $94.8B | $3.8B |
In the fiscal year to Dec 2025, Automotive sales was 69% and Services and other was 13% of revenue; Automotive sales fell from 81% in the fiscal year to Dec 2023.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2023 | Automotive sales | $78.5B | 81% |
| FY2023 | Services and other | $8.3B | 9% |
| FY2023 | Energy generation and storage sales | $5.5B | 6% |
| FY2023 | Automotive leasing | $2.1B | 2% |
| FY2023 | Automotive regulatory credits | $1.8B | 2% |
| FY2023 | Energy generation and storage leasing | $520M | 1% |
| FY2024 | Automotive sales | $72.5B | 74% |
| FY2024 | Services and other | $10.5B | 11% |
| FY2024 | Energy generation and storage sales | $9.6B | 10% |
| FY2024 | Automotive regulatory credits | $2.8B | 3% |
| FY2024 | Automotive leasing | $1.8B | 2% |
| FY2024 | Energy generation and storage leasing | $522M | 1% |
| FY2025 | Automotive sales | $65.8B | 69% |
| FY2025 | Services and other | $12.5B | 13% |
| FY2025 | Energy generation and storage sales | $12.3B | 13% |
| FY2025 | Automotive regulatory credits | $2.0B | 2% |
| FY2025 | Automotive leasing | $1.7B | 2% |
| FY2025 | Energy generation and storage leasing | $501M | 1% |
In the fiscal year to Dec 2025, United States was 50% and Other international was 28% of revenue; United States rose from 47% in the fiscal year to Dec 2023; China was 22%, as in the fiscal year to Dec 2023.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2023 | United States | $45.2B | 47% |
| FY2023 | Other international | $29.8B | 31% |
| FY2023 | China | $21.7B | 22% |
| FY2024 | United States | $47.7B | 49% |
| FY2024 | Other international | $29.0B | 30% |
| FY2024 | China | $20.9B | 21% |
| FY2025 | United States | $47.6B | 50% |
| FY2025 | Other international | $26.2B | 28% |
| FY2025 | China | $21.0B | 22% |
A year earlier $0.39
Diluted, from SEC filings
Quarters: Tesla, Inc.'s SEC filings, named by the month they end. Fiscal years: Tesla, Inc.'s annual reports to the SEC.
How it makes money
Of every $100 in revenue, $4.0 ends up as net income. Net margin fell from 15.4% to 4.0% over the past 3 years.
Show the data
| Quarter ended | Gross | Operating | Net |
|---|---|---|---|
| Dec 2022 | 23.8% | 16.0% | 15.2% |
| Mar 2023 | 19.3% | 11.4% | 10.8% |
| Jun 2023 | 18.2% | 9.6% | 10.8% |
| Sep 2023 | 17.9% | 7.6% | 7.9% |
| Dec 2023 | 17.6% | 8.2% | 31.5% |
| Mar 2024 | 17.4% | 5.5% | 6.5% |
| Jun 2024 | 18.0% | 6.3% | 5.5% |
| Sep 2024 | 19.8% | 10.8% | 8.6% |
| Dec 2024 | 16.3% | 6.2% | 8.3% |
| Mar 2025 | 16.3% | 2.1% | 2.1% |
| Jun 2025 | 17.2% | 4.1% | 5.2% |
| Sep 2025 | 18.0% | 5.8% | 4.9% |
| Dec 2025 | 20.1% | 5.7% | 3.4% |
| Mar 2026 | 21.1% | 4.2% | 2.1% |
| Jun 2026 | 16.8% | 1.4% | 3.9% |
| Sep 2026 | 19.6% | 2.6% | 2.8% |
Circled: Dec 2023 (net 31.5%, operating 8.2%). Net margin is usually less than 1 point above operating margin; in that quarter something below operating income (a tax charge or benefit, a gain or loss on investments, a write-down) moved it, not the business itself.
−7.6 pts over 3 years
−12.2 pts over 3 years
−11.4 pts over 3 years
Each margin is that line of the income statement divided by revenue. Fiscal year: Tesla, Inc.'s annual reports to the SEC; quarters: SEC filings.
Is inventory piling up?
Tesla held $14.1B of inventory at the end of Sep 2026, up 14.8% from a year earlier, while its revenue for the quarter fell 0.2% against the same quarter a year earlier. Inventory outpaced sales by 15.0 points. At the last four quarters' cost of sales, the inventory would last 62 days, against 56 a year earlier.
At the end of Sep 2026, +14.8% on a year earlier
Quarter ended Sep 2026
56 a year earlier
A line beyond the scale runs off it; the legend gives its latest value.
Show the data
| Quarter ended | Inventory | vs a year earlier | Revenue vs a year earlier | Inventory days |
|---|---|---|---|---|
| Dec 2023 | $13.6B | +6.1% | +3.5% | 63 |
| Mar 2024 | $16.0B | +11.5% | −8.7% | 75 |
| Jun 2024 | $14.2B | −1.1% | +2.3% | 66 |
| Sep 2024 | $14.5B | +5.9% | +7.8% | 67 |
| Dec 2024 | $12.0B | −11.8% | +2.1% | 55 |
| Mar 2025 | $13.7B | −14.5% | −9.2% | 63 |
| Jun 2025 | $14.6B | +2.6% | −11.8% | 70 |
| Sep 2025 | $12.3B | −15.5% | +11.6% | 56 |
| Dec 2025 | $12.4B | +3.1% | −3.1% | 58 |
| Mar 2026 | $14.4B | +5.3% | +15.8% | 67 |
| Jun 2026 | $13.8B | −5.6% | +25.5% | 60 |
| Sep 2026 | $14.1B | +14.8% | −0.2% | 62 |
From Tesla, Inc.'s SEC filings: inventory at each quarter end, against the same quarter end a year earlier, and the quarter's revenue against the same quarter a year earlier. Inventory days: inventory over the cost of sales of the four quarters to that date, times 365. Gross margin: gross profit over revenue, by quarter.
Customers and suppliers
In its latest annual report Tesla buys from Samsung, Panasonic, CATL.
Suppliers
Customers
Their customers
Partners
Changes since the previous annual report (10-K filed Jan 30, 2025)
Named in other companies’ filings
Show the filing's words
| Company | Role | In the filing's words |
|---|---|---|
| Samsung | supplier | “In 2025, we further expanded Cortex, our training cluster at Gigafactory Texas, and announced a new collaboration with Samsung to manufacture advanced semiconductors for AI inference and training in the U.S.” |
| Panasonic | supplier | “We are dependent on the continued supply of lithium-ion battery cells for our vehicles and energy storage products, and we will require substantially more cells to grow our business according to our plans. Currently, we rely on suppliers such as Panasonic and Contemporary Amperex Technology Co. Limited (CATL) for these cells.” |
| CATL | supplier | “We are dependent on the continued supply of lithium-ion battery cells for our vehicles and energy storage products, and we will require substantially more cells to grow our business according to our plans. Currently, we rely on suppliers such as Panasonic and Contemporary Amperex Technology Co. Limited (CATL) for these cells.” |
| xAI | partner · Tesla invested in it | “In January 2026, the Company entered into an agreement with xAI to invest approximately $2 billion to acquire shares of Series E Preferred Stock of xAI.” |
| Space Exploration Technologies (424B4 filed Jun 12, 2026) | co-develops with it | “Leveraging shared engineering resources, intellectual property, and infrastructure across Tesla and SpaceX, as well as Intel’s proposed contribution of its expertise in designing, fabricating and packaging ultra-high-performance chips at scale, Terafab creates powerful ecosystem synergies that accelerate innovation cycles and reduce costs.” |
| Space Exploration Technologies (424B4 filed Jun 12, 2026) | calls it a supplier | “During the three months ended March 31, 2026, the Company purchased $34 million of Megapack products from Tesla, Inc. (“Tesla”) recorded in Property, plant, and equipment, net in the consolidated balance sheets.” |
Only the companies Tesla names in its 10-K filed Jan 29, 2026 (SEC). Named in other companies' filings: those whose own latest annual report or an 8-K since names Tesla. The supply chain joins the latest annual reports of the companies on it and the 8-Ks they filed since: a link shows when either side's report names the other, so it grows as more reports are read. Hover a name for the filing's own words.
Is it expensive?
P/E of 437x; earnings are still growing. No peers to compare against.
No peers with a P/E to compare against.
At 437× trailing earnings TSLA is above most of its five-year range; the five-year median is 107×.
Show the data
| Date | Trailing P/E |
|---|---|
| Nov 8, 2021 | 378× |
| Feb 8, 2022 | 189× |
| May 10, 2022 | 109× |
| Aug 10, 2022 | 107× |
| Nov 8, 2022 | 59.2× |
| Feb 9, 2023 | 57.3× |
| May 11, 2023 | 50.6× |
| Aug 11, 2023 | 68.7× |
| Nov 9, 2023 | 67.5× |
| Feb 12, 2024 | 43.8× |
| May 13, 2024 | 43.2× |
| Aug 13, 2024 | 57.7× |
| Nov 11, 2024 | 94.9× |
| Feb 13, 2025 | 174× |
| May 15, 2025 | 196× |
| Aug 15, 2025 | 197× |
| Nov 13, 2025 | 277× |
| Feb 17, 2026 | 380× |
| May 18, 2026 | 376× |
| Aug 18, 2026 | 312× |
| Nov 12, 2026 | 437× |
Closing price over diluted earnings per share of the last four reported quarters, as known on each day (a quarter counts 35 days after it ends). From SEC filings; earnings per share adjusted for splits.
What analysts expect
The average analyst price target is $412, 4% above the current price; 48% of 44 analysts rate it a buy; earnings beat estimates in 3 of the last 4 quarters.
Buy or Strong Buy: 21 analysts (48%). Sell or Strong Sell: 2.
Over the past year the average of the analysts' latest price targets went from $397.87 to $411.95 (+4%), while TSLA went from $401.99 to $397.45 (−1%). In the past three months targets were raised 11 times and cut once. 5 upgrades and 1 downgrade over the year; the latest: Barclays moved it to Overweight from Equal-Weight on Oct 26, 2026.
Show every change
| Date | Firm | Change | Rating | Target |
|---|---|---|---|---|
| Nov 5, 2026 | GLJ Research | Target kept | Sell | $24.86 |
| Oct 26, 2026 | Barclays | Upgrade | Overweight, was Equal-Weight | $450.00, was $370.00 |
| Oct 22, 2026 | UBS | Target raised | Neutral | $425.00, was $391.00 |
| Oct 22, 2026 | CLSA | Upgrade | Hold, was Underperform | $400.00, was $310.00 |
| Oct 22, 2026 | Canaccord Genuity | Target raised | Buy | $442.00, was $410.00 |
| Oct 22, 2026 | Morgan Stanley | Target raised | Equal-Weight | $410.00, was $400.00 |
| Oct 22, 2026 | BNP Paribas | Upgrade | Neutral, was Underperform | $420.00, was $266.00 |
| Oct 22, 2026 | RBC Capital | Target kept | Outperform | $480.00 |
| Oct 22, 2026 | JP Morgan | Target raised | Neutral | $430.00, was $415.00 |
| Oct 22, 2026 | TD Cowen | Target kept | Buy | $460.00 |
| Oct 22, 2026 | Piper Sandler | Target raised | Overweight | $475.00, was $450.00 |
| Oct 22, 2026 | StoneX | Target kept | Buy | $475.00 |
| Oct 22, 2026 | GLJ Research | Target kept | Sell | $24.86 |
| Oct 22, 2026 | Mizuho | Target raised | Outperform | $460.00, was $450.00 |
| Oct 22, 2026 | Cantor Fitzgerald | Target kept | Overweight | $485.00 |
| Oct 22, 2026 | Needham | Rating kept | Hold | — |
| Oct 20, 2026 | Cantor Fitzgerald | Target kept | Overweight | $485.00 |
| Oct 15, 2026 | GLJ Research | Target kept | Sell | $24.86 |
| Oct 12, 2026 | Jefferies | Target raised | Hold | $400.00, was $350.00 |
| Oct 8, 2026 | Tigress Financial | Target kept | Buy | $550.00 |
| Oct 7, 2026 | UBS | Target raised | Neutral | $391.00, was $385.00 |
| Sep 28, 2026 | JP Morgan | Target cut | Neutral | $415.00, was $445.00 |
| Sep 25, 2026 | StoneX | Target kept | Buy | $475.00 |
| Sep 16, 2026 | Goldman Sachs | Target kept | Neutral | $360.00 |
| Sep 4, 2026 | GLJ Research | Target kept | Sell | $24.86 |
| Sep 3, 2026 | StoneX | Target kept | Buy | $475.00 |
| Aug 18, 2026 | GLJ Research | Target kept | Sell | $24.86 |
| Aug 3, 2026 | Stifel | Target cut | Buy | $491.00, was $508.00 |
| Jul 24, 2026 | Piper Sandler | Target cut | Overweight | $450.00, was $500.00 |
| Jul 23, 2026 | UBS | Target cut | Neutral | $385.00, was $442.00 |
| Jul 23, 2026 | JP Morgan | Target cut | Neutral | $445.00, was $475.00 |
| Jul 23, 2026 | Morgan Stanley | Target cut | Equal-Weight | $400.00, was $417.00 |
| Jul 23, 2026 | Truist Securities | Target cut | Hold | $370.00, was $430.00 |
| Jul 23, 2026 | Mizuho | Target cut | Outperform | $450.00, was $480.00 |
| Jul 23, 2026 | TD Cowen | Target cut | Buy | $460.00, was $490.00 |
| Jul 23, 2026 | Canaccord Genuity | Target cut | Buy | $410.00, was $450.00 |
| Jul 23, 2026 | RBC Capital | Target kept | Outperform | $500.00 |
| Jul 23, 2026 | Roth Capital | Target kept | Buy | $505.00 |
| Jul 23, 2026 | Cantor Fitzgerald | Target cut | Overweight | $485.00, was $510.00 |
| Jul 23, 2026 | Needham | Rating kept | Hold | — |
| Jul 21, 2026 | GLJ Research | Target kept | Sell | $24.86 |
| Jul 14, 2026 | Morgan Stanley | Target raised | Equal-Weight | $417.00, was $415.00 |
| Jul 14, 2026 | Barclays | Target raised | Equal-Weight | $370.00, was $360.00 |
| Jul 14, 2026 | Wells Fargo | Target raised | Underweight | $130.00, was $125.00 |
| Jul 13, 2026 | Jefferies | Target raised | Hold | $400.00, was $375.00 |
| Jul 9, 2026 | UBS | Target raised | Neutral | $442.00, was $364.00 |
| Jul 9, 2026 | Citizens | Began coverage | Market Perform | — |
| Jul 7, 2026 | RBC Capital | Target raised | Outperform | $500.00, was $475.00 |
| Jul 2, 2026 | Freedom Broker | Target raised | Hold | $420.00, was $400.00 |
| Jul 2, 2026 | Morgan Stanley | Target kept | Equal-Weight | $415.00 |
| Jul 2, 2026 | Truist Securities | Target raised | Hold | $430.00, was $400.00 |
| Jun 12, 2026 | GLJ Research | Target kept | Sell | $24.86 |
| Jun 5, 2026 | JP Morgan | Upgrade | Neutral, was Underweight | $475.00, was $145.00 |
| Jun 4, 2026 | TD Cowen | Target kept | Buy | $490.00 |
| Apr 23, 2026 | UBS | Target raised | Neutral | $364.00, was $352.00 |
| Apr 23, 2026 | Canaccord Genuity | Target raised | Buy | $450.00, was $420.00 |
| Apr 23, 2026 | RBC Capital | Target cut | Outperform | $475.00, was $480.00 |
| Apr 23, 2026 | TD Cowen | Target kept | Buy | $490.00 |
| Apr 23, 2026 | Cantor Fitzgerald | Target kept | Overweight | $510.00 |
| Apr 23, 2026 | Wedbush | Target kept | Outperform | $600.00 |
| Apr 23, 2026 | Mizuho | Target cut | Outperform | $480.00, was $540.00 |
| Apr 23, 2026 | Needham | Rating kept | Hold | — |
| Apr 22, 2026 | Cantor Fitzgerald | Target kept | Overweight | $510.00 |
| Apr 21, 2026 | Wedbush | Target kept | Outperform | $600.00 |
| Apr 15, 2026 | TD Cowen | Target cut | Buy | $490.00, was $519.00 |
| Apr 14, 2026 | UBS | Upgrade | Neutral, was Sell | $352.00 |
| Apr 6, 2026 | Canaccord Genuity | Target kept | Buy | $420.00 |
| Apr 6, 2026 | Baird | Target cut | Outperform | $538.00, was $548.00 |
| Mar 31, 2026 | Canaccord Genuity | Target cut | Buy | $420.00, was $520.00 |
| Mar 30, 2026 | GLJ Research | Target kept | Sell | $24.86 |
| Mar 27, 2026 | Wedbush | Target kept | Outperform | $600.00 |
| Mar 12, 2026 | GLJ Research | Target kept | Sell | $25.28 |
| Feb 19, 2026 | GLJ Research | Target kept | Sell | $25.28 |
| Jan 30, 2026 | JP Morgan | Target cut | Underweight | $145.00, was $150.00 |
| Jan 29, 2026 | Morgan Stanley | Target cut | Equal-Weight | $415.00, was $425.00 |
| Jan 29, 2026 | RBC Capital | Target kept | Outperform | $500.00 |
| Jan 29, 2026 | Wedbush | Target kept | Outperform | $600.00 |
| Jan 29, 2026 | Cantor Fitzgerald | Target kept | Overweight | $510.00 |
| Jan 29, 2026 | Wells Fargo | Target cut | Underweight | $125.00, was $130.00 |
| Jan 29, 2026 | GLJ Research | Target kept | Sell | $25.28 |
| Jan 29, 2026 | Mizuho | Target raised | Outperform | $540.00, was $530.00 |
| Jan 29, 2026 | Truist Securities | Target cut | Hold | $438.00, was $439.00 |
| Jan 29, 2026 | Needham | Rating kept | Hold | — |
| Jan 29, 2026 | Freedom Broker | Target raised | Hold | $440.00, was $406.00 |
| Jan 23, 2026 | Barclays | Target raised | Equal-Weight | $360.00, was $350.00 |
| Jan 14, 2026 | UBS | Target raised | Sell | $307.00, was $247.00 |
| Jan 12, 2026 | Wells Fargo | Target raised | Underweight | $130.00, was $120.00 |
| Jan 7, 2026 | GLJ Research | Target raised | Sell | $25.28, was $19.05 |
| Jan 2, 2026 | Truist Securities | Target cut | Hold | $439.00, was $444.00 |
| Dec 30, 2025 | Baird | Target kept | Outperform | $548.00 |
| Dec 23, 2025 | Canaccord Genuity | Target raised | Buy | $551.00, was $482.00 |
| Dec 19, 2025 | Deutsche Bank | Target raised | Buy | $500.00, was $470.00 |
| Dec 19, 2025 | Truist Securities | Target raised | Hold | $444.00, was $406.00 |
| Dec 15, 2025 | Wedbush | Target kept | Outperform | $600.00 |
| Dec 9, 2025 | Piper Sandler | Target kept | Overweight | $500.00 |
| Dec 8, 2025 | Morgan Stanley | Downgrade | Equal-Weight, was Overweight | $425.00, was $410.00 |
| Nov 25, 2025 | Mizuho | Target cut | Outperform | $475.00, was $485.00 |
| Nov 17, 2025 | Stifel | Target raised | Buy | $508.00, was $483.00 |
Show the data
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec ’25 | $0.45 | $0.50 | +11.1% |
| Mar ’26 | $0.35 | $0.41 | +17.1% |
| Jun ’26 | $0.54 | $0.33 | −38.9% |
| Sep ’26 | $0.45 | $0.48 | +6.7% |
The day after each of these reports the stock moved −3.3% (Dec 2025, beat); −3.3% (Mar 2026, beat); −15.6% (Jun 2026, missed); +0.2% (Sep 2026, beat).
For the quarter ending Dec 2026 (Tesla reports on Jan 27, 2027), analysts expect adjusted earnings of $0.50 a share, 0.02% more than the $0.50 of a year earlier, and revenue of $29.3B, up 18% on a year earlier. For the fiscal year ending Dec 2027, they expect revenue of $122.4B, up 13% on the year before's estimate.
Adjusted. Dec 2025: $0.50; range $0.34 to $0.88; 27 analysts
Dec 2025: $24.9B; range $26.7B to $35.4B; 28 analysts
The year to Dec 2026: $107.9B expected; range $105.1B to $149.9B; 43 analysts
Show the data
| Period | Figure | Expected | Low to high | Analysts | A year earlier | Change |
|---|---|---|---|---|---|---|
| Quarter ending Dec 2026, results Jan 27, 2027 | EPS (adjusted) | $0.50 | $0.34 to $0.88 | 27 | $0.50 (Dec 2025) | 0% |
| Quarter ending Dec 2026, results Jan 27, 2027 | Revenue | $29.3B | $26.7B to $35.4B | 28 | $24.9B (Dec 2025) | +18% |
| Quarter ending Mar 2027 | EPS (adjusted) | $0.46 | $0.28 to $0.90 | 13 | $0.41 (Mar 2026) | +12% |
| Quarter ending Mar 2027 | Revenue | $26.5B | $24.5B to $31.7B | 15 | $22.4B (Mar 2026) | +18% |
| Year ending Dec 2026 | EPS (adjusted) | $1.72 | $1.17 to $2.28 | 32 | — | — |
| Year ending Dec 2026 | Revenue | $107.9B | $99.6B to $119.4B | 43 | $94.8B (year to Dec 2025) | +14% |
| Year ending Dec 2027 | Revenue | $122.4B | $105.1B to $149.9B | 43 | $107.9B (expected, year to Dec 2026) | +13% |
Targets, ratings and earnings estimates: Yahoo Finance. Rating and target changes: Yahoo Finance's list of upgrades and downgrades. The average target on each day is the average of every listed firm's latest target set in the 180 days before it, so it counts fewer analysts than the average target above, and the band is the middle half of those targets (a quarter of the firms are above it, a quarter below); a target set before a stock split is divided by the split. Expected figures: the average of the analysts' estimates (Yahoo Finance). Their EPS is adjusted, as analysts estimate it, so it is set against the adjusted EPS Yahoo reports for the same quarters, not the GAAP EPS of the growth and valuation sections; revenue against the SEC filings. No change is given against a quarter whose reported EPS was more than 50% off its own estimate (often a one-off gain or charge), nor against a year that counts one. Each estimate is pinned to its fiscal period by the report date or the period's end, and one that cannot be is left out.
Where the cash goes
Generated $3.3B in free cash flow over the year, with no dividends and no buybacks. All of the cash stays in the company.
Show the data
| Line | Amount |
|---|---|
| Op. cash flow | $18.7B |
| Capex | −$15.4B |
| Free cash flow | $3.3B |
| Dividends | — |
| Buybacks | — |
| Cash retained | $3.3B |
For every $100 of market cap, the company generates about $0.2 in free cash flow a year.
No dividend today; cash goes to growth and share buybacks.
Tesla had 3.54B diluted shares in the quarter ended Sep 2026, 0.4% more than a year earlier, and 0.5% more each year on average since Sep 2022. Over the last four quarters its earnings per share fell 37.2% and its net income fell 36.7%: more shares took about 1 point off.
Show the data
| Quarter ended | Diluted shares |
|---|---|
| Sep 2022 | 3.47B |
| Mar 2023 | 3.47B |
| Jun 2023 | 3.48B |
| Sep 2023 | 3.49B |
| Mar 2024 | 3.48B |
| Jun 2024 | 3.48B |
| Sep 2024 | 3.50B |
| Mar 2025 | 3.52B |
| Jun 2025 | 3.52B |
| Sep 2025 | 3.53B |
| Mar 2026 | 3.54B |
| Jun 2026 | 3.54B |
| Sep 2026 | 3.54B |
Free cash flow: operating cash flow minus capital spending on property, plant and equipment, from SEC filings. Shares: each quarter's diluted weighted average as filed with the SEC, since the stock's listing and its latest split.
Financial health
Current ratio 2.2, no pressure to repay short-term debt; debt-to-equity 0.1, debt is very low and the balance sheet is solid.
Assets that can be turned into cash soon are 2.2x what is owed within a year. 1.5 or higher is comfortable; below 1 needs watching.
For every $1 of shareholder funds, there is $0.1 of debt (leases not counted). The higher the number, the more pressure when the economy weakens.
Cash and short-term investments of $44.1B against debt of $8.2B. Lease obligations of $6.6B are not counted: they are rent owed, not money borrowed.
Latest fiscal year balance sheet. Source: Yahoo Finance.
Who holds it
3 portfolios Hunch tracks hold TSLA: 3 funds. It is 24.8% of Prime Capital Management's portfolio (21.6% as filed).
FundPrime Capital ManagementTSLA is 25% of this portfolio+50.1%
FundUNICOM SystemsTSLA is 20% of this portfolio-7.3%
FundStony Point CapitalTSLA is 9% of this portfolio+49.4%
TSLA's weight in each portfolio is its target weight in the copy Hunch follows: the stocks of the latest filing that the app can trade, their weights scaled up to add to 100%. “As filed” is its weight in the filing itself: a fund’s latest 13F, or a member of Congress’s holdings from the last annual report and the trades disclosed since, each at the low end of its range. Returns are backtests based on public filings, not actual trading results. Photo credits
What did the funds Hunch tracks do?
Of the 83 funds whose 13F filings Hunch reads, 24 held TSLA at the end of their latest quarter (for most, Q2 2026). Over that quarter 14 added shares, 7 cut, 1 bought new, 2 sold all and 2 held the same. The largest of them is Norges Bank, 38.81M shares worth $16.3B at Jun 30, 2026, 1.9% more than at Dec 31, 2025.
1 of them new holders
2 of them sold all
Show every fund
| Fund | Quarter | Shares | Value | Change in shares | Change | Filed |
|---|---|---|---|---|---|---|
| Norges Bank | Q2 2026 vs Q4 2025 | 38.81M | $16.3B | +726,279 | +1.9% | Aug 12, 2026 |
| Canada Pension Plan Investment Board | Q2 2026 | 7.48M | $3.1B | +1.42M | +23% | Aug 14, 2026 |
| Swiss National Bank | Q3 2026 | 7.83M | $2.8B | −112,560 | −1.4% | Nov 12, 2026 |
| National Pension Service | Q3 2026 | 6.07M | $2.2B | +43,577 | +0.7% | Nov 12, 2026 |
| Newlands Management Operations | Q2 2026 | 3.77M | $1.6B | 0 | 0.0% | Aug 14, 2026 |
| H&H International Investment | Q2 2026 | 3.38M | $1.4B | −28,500 | −0.8% | Aug 14, 2026 |
| ARK Investment Management | Q2 2026 | 2.76M | $1.2B | −71,529 | −2.5% | Aug 14, 2026 |
| Mirae Asset Global Investments | Q3 2026 | 2.38M | $846M | +223,717 | +10% | Nov 3, 2026 |
| Korea Investment | Q2 2026 | 1.99M | $836M | −109,822 | −5.2% | Aug 12, 2026 |
| Hyperion Asset Management | Q3 2026 | 1.34M | $476M | +112,598 | +9.2% | Oct 20, 2026 |
| Nomura Holdings | Q2 2026 | 958,277 | $403M | +389,951 | +69% | Aug 14, 2026 |
| Tudor Investment Corp Et Al | Q2 2026 | 759,222 | $319M | +174,504 | +30% | Aug 14, 2026 |
| Prime Capital Management | Q3 2026 | 719,861 | $255M | 0 | 0.0% | Nov 6, 2026 |
| Renaissance Technologies | Q3 2026 | 684,145 | $243M | −426,815 | −38% | Nov 12, 2026 |
| Viking Global Investors | Q2 2026 | 547,816 | $230M | −1.95M | −78% | Aug 14, 2026 |
| Baillie Gifford & | Q3 2026 | 642,296 | $228M | −88,345 | −12% | Nov 9, 2026 |
| UNICOM Systems | Q3 2026 | 510,661 | $181M | +62,000 | +14% | Oct 13, 2026 |
| CloudAlpha Capital Management Limited/Hong Kong | Q3 2026 | 0 | — | −243,300 | Sold all | Nov 9, 2026 |
| Stony Point Capital | Q2 2026 | 192,952 | $81.2M | +6,189 | +3.3% | Aug 13, 2026 |
| Soros Fund Management | Q2 2026 | 86,846 | $36.5M | +33,753 | +64% | Aug 14, 2026 |
| Coatue Management | Q2 2026 | 59,963 | $25.2M | +1,125 | +1.9% | Aug 14, 2026 |
| Nan Shan Life Insurance | Q2 2026 | 36,422 | $15.3M | +27,827 | +324% | Aug 14, 2026 |
| Fisher Asset Management | Q3 2026 | 37,587 | $13.3M | +2,163 | +6.1% | Nov 6, 2026 |
| RK Capital Management | Q2 2026 | 10,000 | $4.2M | +10,000 | New | Aug 14, 2026 |
| Polen Capital Management | Q2 2026 | 8,974 | $3.8M | +1,606 | +22% | Aug 4, 2026 |
| Bridgewater Associates | Q2 2026 | 0 | — | −2,017 | Sold all | Aug 14, 2026 |
From the 13F filings of the 83 funds Hunch tracks, not of every institution: each fund's shares of TSLA at its latest quarter end against the quarter before, as filed (long positions only, options left out), the quarter before put on the latest quarter's share count across a split. A fund files 45 days after its quarter ends, so some have a newer quarter than others. Value is at the quarter end. Norges Bank filed its 13F for Q1 2026 confidentially, with no holdings made public, so its row compares Q2 2026 with Q4 2025.
Are insiders buying or selling?
Officers and directors sold $82.3M of TSLA on the open market in the 12 months to Nov 12, 2026; none bought. 69% of the sales were made under 10b5-1 plans, set up in advance. The largest was Kathleen Wilson-Thompson (Director), who sold $30.0M in 38 sales.
61 sales
0 purchases
Share of the sales' value
Show every trade
| Date | Insider | Role | Trade | Shares | Price | Value | Filed |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 840 | $369.01 | $310K | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 1,520 | $369.77 | $562K | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 1,275 | $370.93 | $473K | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 1,020 | $371.88 | $379K | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 619 | $372.82 | $231K | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 520 | $374.40 | $195K | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 280 | $375.15 | $105K | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 1,081 | $376.69 | $407K | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 3,003 | $377.49 | $1.1M | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 3,480 | $378.57 | $1.3M | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 1,760 | $379.43 | $668K | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 1,755 | $380.76 | $668K | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 6,896 | $381.61 | $2.6M | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 680 | $382.41 | $260K | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 1,240 | $383.61 | $476K | May 4, 2026 |
| Apr 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 440 | $384.28 | $169K | May 4, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 2,000 | $352.83 | $706K | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 1,640 | $353.66 | $580K | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 1,800 | $354.80 | $639K | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 2,481 | $355.64 | $882K | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 2,360 | $356.79 | $842K | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 1,120 | $357.84 | $401K | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 520 | $358.77 | $187K | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 1,880 | $360.18 | $677K | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 1,000 | $361.04 | $361K | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 2,320 | $362.14 | $840K | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 4,001 | $363.08 | $1.5M | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 3,927 | $363.95 | $1.4M | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 560 | $364.89 | $204K | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 120 | $365.90 | $44K | Apr 1, 2026 |
| Mar 30, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 80 | $366.86 | $29K | Apr 1, 2026 |
| Feb 25, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 80 | $412.46 | $33K | Feb 27, 2026 |
| Feb 25, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 4,777 | $413.95 | $2.0M | Feb 27, 2026 |
| Feb 25, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 7,501 | $414.85 | $3.1M | Feb 27, 2026 |
| Feb 25, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 6,825 | $415.86 | $2.8M | Feb 27, 2026 |
| Feb 25, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 3,148 | $416.82 | $1.3M | Feb 27, 2026 |
| Feb 25, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 2,960 | $417.52 | $1.2M | Feb 27, 2026 |
| Feb 25, 2026 | Kathleen Wilson-Thompson | Director | Sale (10b5-1 plan) | 440 | $418.89 | $184K | Feb 27, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 1,803 | $435.87 | $786K | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 1,685 | $437.20 | $737K | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 3,004 | $438.19 | $1.3M | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 1,611 | $439.23 | $708K | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 5,679 | $440.17 | $2.5M | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 6,167 | $441.16 | $2.7M | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 6,049 | $442.24 | $2.7M | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 3,749 | $443.29 | $1.7M | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 3,055 | $444.33 | $1.4M | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 3,575 | $445.27 | $1.6M | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 2,304 | $446.40 | $1.0M | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 2,519 | $447.44 | $1.1M | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 731 | $448.28 | $328K | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 600 | $449.51 | $270K | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 1,260 | $450.51 | $568K | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 3,306 | $451.62 | $1.5M | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 3,891 | $452.62 | $1.8M | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 5,927 | $453.51 | $2.7M | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 600 | $454.62 | $273K | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 1,191 | $455.95 | $543K | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 680 | $457.14 | $311K | Jan 6, 2026 |
| Jan 2, 2026 | James R Murdoch | Director | Sale (10b5-1 plan) | 614 | $457.88 | $281K | Jan 6, 2026 |
| Dec 9, 2025 | Kimbal Musk | Director | Sale | 56,820 | $450.66 | $25.6M | Dec 11, 2025 |
From the Form 4s filed with the SEC about Tesla, Inc. (15 in the 12 months): purchases (code P) and sales (code S) on the open market by its officers and directors, at the price each filing gives (often an average of the day's trades). A sale is a 10b5-1 sale when its filing says it was made under such a plan, set up in advance. Not counted: 20 other transactions (option exercises, shares withheld for tax, shares sold to pay tax, gifts and other transfers).